Venture Capital
New York, New York, 10019
Longevity Vision Fund (LVF) was founded by Sergey Young and a team of investment and scientific experts in 2019 to invest in technologies with the potential to disrupt life sciences and healthcare to help people live longer and healthier lives. Its mission is to accelerate longevity breakthroughs and to make them more accessible and affordable to everyone. LVF has grown its portfolio to 18 companies across therapeutic platforms, AI-enabled drug discovery, and diagnostics. LVF was honored as a World Changing Idea in Impact Investing by Fast Company in 2021 and 2022, along with the top 15 leading impact investing funds. Sergey Young, the Founder, is a longevity investor and visionary with a mission to extend the healthy lifespans of at least one billion people and make longevity more affordable and accessible to everyone. Following 20 years of investment expertise managing PE & VC funds, he founded LVF to invest in leading biotech companies targeting the underlying causes of aging.
05624sbs
